EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease

Kaiying He, Xiaochun Zhou, Jing Zhao, Hongxuan Du, Juan Guo, Rongrong Deng, Jianqin Wang

Biochemical Genetics · 2024

DOI: 10.1007/s10528-024-10688-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Genetics, 2024. Verfasst von Kaiying He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Lanzhou University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: MicroRNAs, Fibrosis, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a serious threat to human health worldwide, and its incidence is increasing annually. A growing amount of information is emerging about the role of micoRNAs (miRNAs) in the regulation of renal fibrosis, which has aroused interest in the development of drugs that block pathogenic miRNAs or restore protective miRNAs levels. To clarify the role of miRNAs in CKD, we selected patients with significant renal fibrotic disease (diabetic nephropathy (DN) and focal segmental glomerulosclerosis (FSGS)) as the disease group, and patients with little or no renal fibrotic disease (minimal change disease (MCD) and renal carcinoma adjacent to normal kidney) as controls. Significantly differentially expressed miRNAs were obtained by human kidney tissue sequencing, subsequently verified in mice models of DN and FSGS, and subsequently inhibited or overexpressed in human renal tubular epithelial cells (HK-2) stimulated by high glucose (HG) and TGF-β1 in vitro. Therefore, the mechanism of its action in renal fibrosis was further elaborated. Finally, the downstream target genes of the corresponding miRNAs were verified by bioinformatics analysis, qRT-PCR, western blot and double luciferase report analysis. Two novel miRNAs, hsa-miR-1470-3p (miR-1470) and hsa-miR-4483-3p (miR-4483), were detected by renal tissue sequencing in the disease group with significant renal fibrosis (DN and FSGS) and the control group with little or no renal fibrosis (MCD and normal renal tissue adjacent to renal carcinoma). Subsequent human renal tissue qRT-PCR verified that the expression of miR-1470 was significantly increased, while the expression of miR-4483 was markedly decreased in the disease group ( p < 0.05). Moreover, in vivo DN and FSGS mice models, the expression levels of miR-1470 and miR-4483 were consistent with the results of human kidney tissue. In vitro, miR-4483 was suppressed, whereas miR-1470 was induced by treatment with TGF-β1 or HG. Inhibition of miR-1470 or overexpression of miR-4483 promoted HG or TGF-β1-induced fibrosis in HK-2 cells. Further study revealed that MMP-13 and TIMP1 were the target genes ofmiR-1470 and miR-4483, respectively. Our study identifies newly dysregulated miRNA profiles related to fibrosis kidneys. miR-1470 and miR-4483 are demonstrated to participate in kidney fibrosis by regulation of MMP-13, TIMP1 respectively. Our results may represent a promising research direction for renal disorders and help identify new biomarkers and therapeutic targets for CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsFibrosisRenal Insufficiency, ChronicHumansAnimalsMiceMaleDisease ProgressionGlomerulosclerosis, Focal SegmentalDiabetic NephropathiesFemaleMice, Inbred C57BLMiddle AgedCell LineKidney

Stichwörter der Autor:innen

Chronic kidney diseaseDNFSGSNovel miRNAsRenal fibrosis

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Lanzhou University, Lanzhou, Gansu, China.
  • Department of Nephrology, The Second Hospital & Clinical Medical School, Lanzhou University, No. 82 Cuiyingmen, Lanzhou, Gansu, China.
  • Xi'an Huyi District Hospital Of Traditional Chinese Medicine, Xi'an, Shaanxi, China.
  • Department of Nephrology, The Second Hospital & Clinical Medical School, Lanzhou University, No. 82 Cuiyingmen, Lanzhou, Gansu, China. ery_wangjqery@lzu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

He, K., Zhou, X., Zhao, J., Du, H., Guo, J., Deng, R., & Wang, J. (2024). Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease. Biochemical Genetics. https://doi.org/10.1007/s10528-024-10688-7

Vancouver

He K, Zhou X, Zhao J, Du H, Guo J, Deng R, et al. Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease. Biochemical Genetics. 2024. doi:10.1007/s10528-024-10688-7

BibTeX
@article{He2024,
  author = {He, Kaiying and Zhou, Xiaochun and Zhao, Jing and Du, Hongxuan and Guo, Juan and Deng, Rongrong and Wang, Jianqin},
  title = {Identification and Functional Mechanism Verification of Novel MicroRNAs Associated with the Fibrosis Progression in Chronic Kidney Disease},
  journal = {Biochemical Genetics},
  year = {2024},
  doi = {10.1007/s10528-024-10688-7}
}
Kostenlos starten →